Ignite Creation Date:
2024-05-05 @ 5:26 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00454168
Status:
UNKNOWN
Last Update Posted:
2014-01-06
First Post:
2007-03-27
Brief Title:
Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in Remission
Sponsor:
The Vaccine Company
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Leukemia |
Keywords:
| Name | View |
|---|---|
| adult acute megakaryoblastic leukemia M7 | View |
| adult acute minimally differentiated myeloid leukemia M0 | View |
| adult acute myeloblastic leukemia with maturation M2 | View |
| adult acute myeloblastic leukemia without maturation M1 | View |
| adult acute myeloid leukemia in remission | View |
| adult acute myeloid leukemia with 11q23 MLL abnormalities | View |
| adult acute myeloid leukemia with inv16p13q22 | View |
| adult acute myeloid leukemia with t1517q22q12 | View |
| adult acute myeloid leukemia with t1616p13q22 | View |
| adult acute myeloid leukemia with t821q22q22 | View |
| adult acute myelomonocytic leukemia M4 | View |
| adult acute promyelocytic leukemia M3 | View |
| secondary acute myeloid leukemia | View |
| adult acute monoblastic leukemia M5a | View |
| adult acute monocytic leukemia M5b | View |
| adult erythroleukemia M6a | View |
| adult pure erythroid leukemia M6b | View |